. Author manuscript; available in PMC: 2016 Dec 1.

Published in final edited form as: J Thorac Oncol. 2015 Dec;10(12):1776–1784. doi: 10.1097/JTO.0000000000000680

Table 4.

Baseline characteristics, treatment-related variables, and long-term outcomes in propensity score matched patients with clinical stage I NSCLC who received sublobar resection (wedge resection or segmentectomy) vs. SBRT.

	Surgery (n=4555)		SBRT (n=4555)		P value
Age (years)	73.7 ± 8.2		73.8 ± 8.5		0.751

Female Gender	2504 (55.0%)		2556 (56.1%)		0.282

Caucasian	4166 (91.5%)		4164 (91.4%)		0.940

Urban Location	3214 (70.6%)		3193 (70.1%)		0.646

Income >$35000/year	3119 (68.5%)		3139 (68.9%)		0.651

Charlson/Deyo Score	0	2525 (55.4%)	0	2459 (54.0%)	0.366
	1	1378 (30.3%)	1	1414 (31.0%)
	2	652 (14.3%)	2	682 (15.0%)

Tumor Size (mm)	21.8 ± 9.4		21.9 ± 8.6		0.481

Clinical T stage	T1	3641 (79.9%)	T1	3647 (80.1%)	0.896
Clinical T stage	T2	914 (20.1%)	T2	908 (19.9%)	0.896

Facility Reporting Case	Nonacademic 2674 (58.7%)		Nonacademic 2726 (59.8%)		0.268
Facility Reporting Case	Academic 1881 (41.3%)		Academic 1829 (40.2%)		0.268

Type of operation	Wedge 3745 (82.2%)
Type of operation	Segment 810 (17.8%)

Chemotherapy administered	394 (8.7%)		187 (4.2%)		<0.001

Radiation administered	360 (7.9%)		4555 (100%)		<0.001

Median radiation dose (cGy)	5940 (n=256)		5400 (n=4555)

Median Survival (months)	48.3 ± 1.2		33.9 ± 0.9		<.001